Northwest Biotherapeutics Limited is an active company incorporated on 26 June 2014 with the registered office located in London, City of London. Northwest Biotherapeutics Limited was registered 11 years ago.
Total exemption full accounts made up to 31 December 2024
Submitted on 30 Sep 2025
Registered office address changed from C/O Clyde & Co Llp,, St Botolph Building 138 Houndsditch London EC3A 7AR United Kingdom to C/O Clyde & Co Llp, St Botolph Building 138 Houndsditch London EC3A 7AR on 1 September 2025
Submitted on 1 Sep 2025
Registered office address changed from The St Botolph Building, 138 Houndsditch London EC3A 7AR United Kingdom to C/O Clyde & Co Llp,, St Botolph Building 138 Houndsditch London EC3A 7AR on 21 August 2025
Submitted on 21 Aug 2025
Confirmation statement made on 11 January 2025 with no updates
Submitted on 20 Mar 2025
Total exemption full accounts made up to 31 December 2023
Submitted on 30 Sep 2024
Registered office address changed from Suite 1, 3rd Floor 11-12 st. James's Square London SW1Y 4LB United Kingdom to The St Botolph Building, 138 Houndsditch London EC3A 7AR on 22 January 2024
Submitted on 22 Jan 2024
Withdrawal of a person with significant control statement on 19 January 2024
Submitted on 19 Jan 2024
Confirmation statement made on 11 January 2024 with no updates
Submitted on 19 Jan 2024
Notification of Northwest Biotherapeutics, Inc. as a person with significant control on 18 January 2024
Submitted on 19 Jan 2024
Termination of appointment of Vistra Cosec Limited as a secretary on 11 December 2023